A Molecular Substrate for Long QT in HIV Patients: Tat Protein Reduces IKR in Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes

被引：0
|
作者：
Es-Salah-Lamoureux, Zeineb [1 ]
Jouni, Mariam [1 ]
Belbachir, Nadjet [1 ]
Gandon-Renard, Marine [1 ]
Beaumelle, Bruno [2 ]
Baro, Isabelle [1 ]
Charpentier, Flavien [1 ]
Zibara, Kazem [3 ]
Lemarchand, Patricia [1 ]
Gaborit, Nathalie [1 ]
Loussouarn, Gildas [1 ]
机构：
[1] INSERM U1087 CNRS U6291, Nantes 1, France
[2] CNRS, CPBS FRE 3689, Montpellier, France
[3] Lebanese Univ, Lab Stem Cells, ER045, PRASE, Beirut, Lebanon
来源：
BIOPHYSICAL JOURNAL | 2016年 / 110卷 / 03期
关键词：
D O I：
10.1016/j.bpj.2015.11.612
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
529-Pos
引用
收藏
页码：103A / 103A
页数：1
相关论文
共 50 条
  • [1] Substrate Optimization For Patients With Melas And Leigh Syndrome Using Induced Pluripotent Stem Cells-derived Cardiomyocytes
    Yamamoto, Taylor H.
    Huang, Constance C.
    Cutright, Ava K.
    Dinchman, Kenan C.
    Cohen, Bruce H.
    Chilian, William M.
    Kang, Patrick T.
    CIRCULATION RESEARCH, 2023, 133
  • [2] Mitochondrial Distribution in Human Pluripotent Stem Cells-Derived Cardiomyocytes
    Ku, Seung-Yup
    Kim, Yoon Young
    Huh, Yul
    Lee, Eun-Ju
    Lee, Sang-Hoon
    Kim, Seok Hyun
    Moon, Shin Yong
    Choi, Young Min
    REPRODUCTIVE SCIENCES, 2012, 19 (S3) : 225A - 226A
  • [3] Long QT Syndrome Modelling with Cardiomyocytes Derived from Human-induced Pluripotent Stem Cells
    Sala, Luca
    Gnecchi, Massimiliano
    Schwartz, Peter J.
    ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2019, 8 (02) : 105 - 110
  • [4] Engineering of human induced pluripotent stem cells-derived cardiomyocytes for therapy and disease modelling
    Dulak, J.
    FEBS OPEN BIO, 2019, 9 : 37 - 37
  • [5] Recapitulating Long QT Syndrome Phenotype in Induced Pluripotent Stem Cells-Derived Cardiomyocytes Using CRISPR/Cas9 Technology
    Ge, Ning
    Liu, Min
    Krawczyk, Janusz
    Mcinerney, Veronica
    Galvin, Joseph
    Ward, Deirdre
    McGorrian, Catherine
    O'Brien, Timothy
    Shen, Sanbing
    Prendiville, Terence W.
    CIRCULATION, 2021, 144
  • [6] A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes
    Ahmed, Razan Elfadil
    Anzai, Tatsuya
    Chanthra, Nawin
    Uosaki, Hideki
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [7] Heme oxygenase-1 modulates the properties of human induced pluripotent stem cells-derived cardiomyocytes
    Jez, M.
    Stepniewski, J.
    Andrysiak, K.
    Kania, A.
    Palus-Chramiec, K.
    Lewandowski, M. H.
    Jozkowicz, A.
    Dulak, J.
    HUMAN GENE THERAPY, 2018, 29 (12) : A139 - A140
  • [8] Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes
    Kuusela, Jukka
    Kujala, Ville J.
    Kiviaho, Anna
    Ojala, Marisa
    Swan, Heikki
    Kontula, Kimmo
    Aalto-Setala, Katriina
    SPRINGERPLUS, 2016, 5 : 1 - 13
  • [9] Electrophysiological characterization of human induced pluripotent stem cell derived cardiomyocytes with long QT syndrome type 3
    Malan, D.
    Zhang, M.
    Schulze-Bahr, E.
    Fleischmann, B. K.
    Greber, B.
    Sasse, P.
    ACTA PHYSIOLOGICA, 2015, 213 : 114 - 114
  • [10] Therapeutic Efficacy of the Exosomes Derived From Human Induced Pluripotent Stem Cells (iPSCs) vs. Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes (iCMs) in Murine Myocardial Injury Model
    Fu, Xuebin
    Sano, Hiromi
    von Bornstaedt, Daniel
    Woo, Joseph
    Yang, Phillip
    CIRCULATION, 2017, 136
12345